Sample: CHC364T;;Gender: female;;Age at onset: 44 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC382T;;Gender: female;;Age at onset: 45 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC471T;;Gender: female;;Age at onset: 30 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC466T;;Gender: female;;Age at onset: 50 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC364T;;Gender: female;;Age at onset: 44 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC471T;;Gender: female;;Age at onset: 30 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC466T;;Gender: female;;Age at onset: 50 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC382T;;Gender: female;;Age at onset: 45 years;;Disease: Inflammatory hepatocellular adenomas (IHCA);;Tissue: tumor liver.
Sample: CHC357N;;Gender: female;;Age at onset: 28 years;;Disease: hepatocellular adenoma;;Tissue: non tumoral liver.
Sample: CHC535N;;Gender: female;;Age at onset: 30 years;;Disease: hepatocellular adenoma;;Tissue: non tumoral liver.
Sample: CHC562N;;Gender: female;;Age at onset: 33 years;;Disease: hepatocellular adenoma;;Tissue: non tumoral liver.
Sample: CHC573N;;Gender: female;;Age at onset: 28 years;;Disease: hepatocellular adenoma;;Tissue: non tumoral liver.
Juvenile pilocytic astrocytoma;Age: 6 Sex: F;Location: cerebellum;Histopathology: nd
Juvenile pilocytic astrocytoma;Age: 3 Sex: F;Location: cerebellum;Histopathology: conspicuous vascular proliferation in most areas
Juvenile pilocytic astrocytoma;Age: 6 Sex: F;Location: cerebellum;Histopathology: Ki-67 (4-5%)
Juvenile pilocytic astrocytoma;Age: 13 Sex: F;Location: cerebellum;Histopathology: variable cellularity, prominent blood vessels
Juvenile pilocytic astrocytoma;Age: 9 Sex: F;Location: cerebellum;Histopathology: highly vascular with vascular proliferation noted
Normal Cerebellar tissue;Age: 8 Sex: F;Location: cerebellum;Histopathology: normal
normal cerebellar tissue;Age: 16 Sex: M;Location: cerebellum;Histopatholgy: normal
Normal cerebellar tissue;Age: 63 Sex: M;Location: cerebellum;Histopathology: normal
Dissected mesenchymal villous tissue of early pregnancy was arranged radially on 80 μl drops of growth-factor-reduced Matrigel™ (BD, Bedford, MA) in 24 well plates (SFM; DMEM:Ham's F12 (Gibco) 1:1, supplemented with 100 µg/ml streptomycin/penicillin (Gibco) and incubated for 4 hours at 37°C, 5% CO2 to allow attachment. Wells were then carefully flooded with 500 µl SFM, incubated at 37°C, 5% CO2 and subsequent growth characteristics were monitored by light microscopy. Total RNA or tissue sections were  prepared after 72 hours of incubation.
Dissected mesenchymal villous tissue of early pregnancy was arranged radially on 80 μl drops of growth-factor-reduced Matrigel™ (BD, Bedford, MA) in 24 well plates (SFM; DMEM:Ham's F12 (Gibco) 1:1, supplemented with 100 µg/ml streptomycin/penicillin (Gibco) and incubated for 4 hours at 37°C, 5% CO2 to allow attachment. Wells were then carefully flooded with 500 µl SFM, incubated at 37°C, 5% CO2 and subsequent growth characteristics were monitored by light microscopy. Total RNA or tissue sections were  prepared after 72 hours of incubation.
Dissected mesenchymal villous tissue of early pregnancy was arranged radially on 80 μl drops of growth-factor-reduced Matrigel™ (BD, Bedford, MA) in 24 well plates (SFM; DMEM:Ham's F12 (Gibco) 1:1, supplemented with 100 µg/ml streptomycin/penicillin (Gibco) and incubated for 4 hours at 37°C, 5% CO2 to allow attachment. Wells were then carefully flooded with 500 µl SFM, incubated at 37°C, 5% CO2 and subsequent growth characteristics were monitored by light microscopy. Total RNA or tissue sections were  prepared after 72 hours of incubation.
Dissected mesenchymal villous tissue of early pregnancy was arranged radially on 80 μl drops of growth-factor-reduced Matrigel™ (BD, Bedford, MA) in 24 well plates (SFM; DMEM:Ham's F12 (Gibco) 1:1, supplemented with 100 µg/ml streptomycin/penicillin (Gibco) and incubated for 4 hours at 37°C, 5% CO2 to allow attachment. Wells were then carefully flooded with 500 µl SFM, incubated at 37°C, 5% CO2 and subsequent growth characteristics were monitored by light microscopy. Total RNA or tissue sections were prepared after 72 hours of incubation.
Dissected mesenchymal villous tissue of early pregnancy was arranged radially on 80 μl drops of growth-factor-reduced Matrigel™ (BD, Bedford, MA) in 24 well plates (SFM; DMEM:Ham's F12 (Gibco) 1:1, supplemented with 100 µg/ml streptomycin/penicillin (Gibco) and incubated for 4 hours at 37°C, 5% CO2 to allow attachment. Wells were then carefully flooded with 500 µl SFM, incubated at 37°C, 5% CO2 and subsequent growth characteristics were monitored by light microscopy. Total RNA or tissue sections were prepared after 72 hours of incubation.
Dissected mesenchymal villous tissue of early pregnancy was arranged radially on 80 μl drops of growth-factor-reduced Matrigel™ (BD, Bedford, MA) in 24 well plates (SFM; DMEM:Ham's F12 (Gibco) 1:1, supplemented with 100 µg/ml streptomycin/penicillin (Gibco) and incubated for 4 hours at 37°C, 5% CO2 to allow attachment. Wells were then carefully flooded with 500 µl SFM, incubated at 37°C, 5% CO2 and subsequent growth characteristics were monitored by light microscopy. Total RNA or tissue sections were prepared after 72 hours of incubation